Advances in Hepatocellular and Biliary Tract Cancers Impacting Patient Outcomes

Get up to date with downloadable slides from a live symposium and an expert commentary on contemporary management of HCC and BTCs.

Share

Program Content

Activities

Advanced HCC Treatment
Contemporary Systemic Therapy for Advanced HCC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

View Activity
Early HCC Treatment
Systemic Therapy Combinations for Early- and Intermediate-Stage HCC: Current Evidence and Ongoing Trials
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

View Activity
Advanced BTC Treatment
Immunotherapy and Targeted Therapy Regimens for Biliary Tract Cancers
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

View Activity

Activities

Topics in Hepatobiliary Cancer Treatment
Experts Discuss Key Topics in Treating Hepatobiliary Cancers
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2023

View Activity

Faculty

cover img faculity

Thomas A. Abrams, MD

Institute Physician
Director, Liver Tumor Center
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Mitesh Borad, MD

Professor of Medicine 
Hematology Oncology 
Mayo Clinic 
Phoenix, Arizona 

cover img faculity

Stacey Stein, MD

Associate Professor of Medicine
Department of Medical Oncology
Yale University
Medical Oncologist
GI Oncology
Yale Cancer Center
New Haven, Connecticut

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

Supporters

Supported by an educational from AstraZeneca.

AstraZeneca

Partners

Clinical Care Options, LLC

ProCE Banner